Sign in Subscribe

Curium to Acquire Lantheus in Up to $8 Billion Radiopharma Deal

Curium will buy Lantheus for $102.50/share cash plus up to $12 CVRs, valuing the radiopharma deal at up to $8B. Closing expected in H1 2027.

Curium to Acquire Lantheus in Up to $8 Billion Radiopharma Deal
"Prostate cancer visualized by ultrasound." Credit: BSIP/Universal Images Group Editorial/Getty Images
Already have an account? Sign in.